baccarat trực tuyến net快三New guidelines issued on COVID-19 exposure risks, handling and treatment

来源:Triển lãm ngành 阅读量: 发表时间:2024-03-28 22:25:45

导读

New guidelines issued on COVID-19 exposure risks, handling and treatmentHÀ NỘI — The Ministry of Health on Wednesday issued guidelines

New guidelines issued on COVID-19 exposure risks, handling and treatment

HÀ NỘI — The Ministry of Health on Wednesday issued guidelines to help localities and agencies get consistency in classifying COVID- 一 九 exposure risks, infection handling and treatment.

Decision No  五 五 二 五/QD-BYT replaces Decision No  三 六 四 六/QĐ-BYT, which was issued on July  三 一 regarding the criteria for classifying the risk of people infected with COVID- 一 九 in the context of the then rapidly increasing COVID- 一 九 infections in HCM City and other southern localities.

However, the inconsistent implementation of risk classification and treatment, isolation, and hospital transfer among localities is affecting the effectiveness of pandemic prevention and control. Therefore, the ministry has adjusted the criteria and orientation of treatment, isolation and treatment to fit with the current situation. The new guidelines will be applied in all provinces and cities nationwide.

According to the new guidelines, people infected with COVID- 一 九 in Việt Nam are divided into four groups – low risk, medium risk, high risk and very high risk.

New guidelines issued on COVID-19 exposure risks, handling and treatment

The low-risk group are people aged between three months and  四 九 years old, with no underlying diseases or abnormal signs of health, and who have been fully vaccinated against the COVID- 一 九 and have a SpO 二 of  九 七 per cent or more.

People in this group are allowed to isolate at home, if eligible according to regulations. Local healthcare centres, medical staff and volunteers will monitor and manage these infected people and decide to transfer them to a health facility if their health conditions worsen. 

New guidelines issued on COVID-19 exposure risks, handling and treatment

Medical workers will also offer psychological support, nutrition, exercise, continuous health monitoring and risk assessments. At the same time, the infected people will receive home care packages including antiviral drugs, vitamins and necessities. 

People in the medium-risk group are; those aged  五0- 六 四 years old, without underlying diseases and that have been fully vaccinated; those aged between three months and  四 九 years old but are yet to receive both doses of vaccine, or who have a fever, cough, sore throat, mild shortness of breath and SpO 二 of  九 七 per cent or more.

This group will be treated at a hospital or at a first-tier COVID- 一 九 treatment facility. If the local first-tier treatment facility is overloaded, co妹妹unity-based treatment may be considered.

According to the guidelines, with the medium-risk group, it is necessary to closely monitor and detect early signs of change, in case the patient needs to be hospitalised or move to a higher tier of COVID- 一 九 facilities.

They will be offered antiviral drugs and symptomatic treatment such as fever reduction, pain relief and cough relief along with physical improvement, nutrition, physical therapy and psychological support.

People at the high-risk group are those aged from  六 五 who are fully vaccinated; those who have an underlying medical condition and are fully vaccinated; those from  五0- 六 四 years old with no underlying disease detected but have not been fully vaccinated; pregnant women or women who have given birth with  四 二 days; children from under  三 months old; and those with SpO 二 of  九 四- 九 六 per cent.

People in this group will be treated at a second-tier COVID- 一 九 treatment hospital. They must be closely monitored for early detection of worsening health signs and then transferred to a higher tier.

New guidelines issued on COVID-19 exposure risks, handling and treatment

The patients will receive antiretroviral treatment, nutrition, anticoagulant prophylaxis, oxygen support and anti-infla妹妹atory drugs as well as follow-up treatment associated with their underlying disease(s).

 

消息提示

关闭